Can intra‐operative GH measurement in acromegalic subjects predict completeness of surgery?
- 1 July 1998
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 49 (1) , 45-51
Abstract
OBJECTIVE: Results of trans‐sphenoidal pituitary surgery, in terms of long‐term cure, vary considerably between centres. Additional techniques, which can assist the neurosurgeon in deciding whether surgery is complete or not, might therefore be important. One such potential tool is the intra‐operative measurement of GH and calculating the plasma half‐life from the plasma samples obtained after the presumed complete resection of the adenoma.METHODS: GH half‐life was calculated from 5–10 min plasma samples after adenomectomy in 20 patients. GH was measured with a sensitive and rapid IFMA, and the results could be reported within 30 min, but were not used in this study for per‐operative decisions. Cure was defined by a glucose suppressed plasma GH concentration below 1 mU/l (0.38 μg/l) during follow‐up studies and a normal plasma IGFI concentration.RESULTS: In 13 cured patients the plasma half‐life was 22.2 ± 1.9 min (range 14–40.6). In three non‐cured patients the plasma half‐life could not be calculated, and in four other patients the plasma half‐life was 35.8 ± 5.9 min (range 25.8–51 min). By applying 25 min as the upper normal limit for the GH plasma half‐life, the sensitivity was 77%, specificity 100%, and positive predictive value 100%.CONCLUSION: Per‐operative plasma GH monitoring is a potentially useful tool for determining the completeness of trans‐sphenoidal surgery in acromegaly.Keywords
This publication has 21 references indexed in Scilit:
- Intraoperative Adrenocorticotropin Levels During Transsphenoidal Surgery for Cushing's Disease Do Not Predict CureThe Journal of Clinical Endocrinology & Metabolism, 1997
- Circulating Non-22-Kilodalton Growth Hormone Isoforms in Acromegalic Men before and after Transsphenoidal SurgeryThe Journal of Clinical Endocrinology & Metabolism, 1997
- Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cureClinical Endocrinology, 1996
- Retrospective analysis of long‐term surgical results in acromegaly: preoperative and postoperative factors predicting outcomeClinical Endocrinology, 1996
- Surgical outcome after repeated transsphenoidal surgery in acromegalyJournal of Neurosurgery, 1996
- Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failureJournal of Neurosurgery, 1993
- Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patientsJournal of Neurosurgery, 1988
- PLASMA GROWTH HORMONE HALF-LIFE AFTER SELECTIVE REMOVAL OF ADENOMA IN ACROMEGALICS DETERMINES THE OUTCOME OF SURGERYClinical Endocrinology, 1988
- Recent developments in the treatment of acromegalyNeurosurgical Review, 1985
- HOW EFFECTIVE IS EXTERNAL PITUITARY IRRADIATION FOR GROWTH HORMONE‐SECRETING PITUITARY TUMOURS?Clinical Endocrinology, 1984